Skip to main content
. Author manuscript; available in PMC: 2016 Aug 25.
Published in final edited form as: Cell Rep. 2015 Aug 13;12(8):1252–1260. doi: 10.1016/j.celrep.2015.07.039

Figure 4. Mutation of Phe629 Does Not Affect PKC Activation.

Figure 4

Normalized FRET ratio changes (mean ± SEM) showing agonist-dependent PKC activity of the indicated RFP-tagged PKCβII constructs or RFP control (endogenous) in COS7 cells co-expressing CKAR.